Advent Venture Partners LLP has raised £75 million for a new fund devoted exclusively to life science investments. The fund will invest primarily in early and mid-stage companies in the UK, Europe and the US. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
